Dabigatran-etexilate/recombinant-staphylokinase-supergeneBrain haemorrhage: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1920卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21719-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：182 / 182

相关论文

共 50 条

[31] Dabigatran-etexilate/heparinThrombocytopenia and oozing: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 123 - 123
[32] Dabigatran-etexilate/warfarinVarious toxicities: 10 case reports
Reactions Weekly, 2020, 1785 (1) : 177 - 177
[33] Aspirin/dabigatran-etexilate/rivaroxabanBleeding: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 75 - 75
[34] Dabigatran etexilate/idarucizumabIntracranial haemorrhage and lack of efficacy: case report
Reactions Weekly, 2024, 2028 (1) : 158 - 158
[35] Dabigatran etexilate overdosePulmonary haemorrhage in an elderly patient: case report
Reactions Weekly, 2013, 1471 (1) : 20 - 20
[36] Apixaban/dabigatran-etexilate/warfarinBleeding: 4 case reports
Reactions Weekly, 2021, 1837 (1) : 82 - 82
[37] Dabigatran-etexilate/DoxycyclineLack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2021 (1) : 165 - 165
[38] Alteplase/dabigatran-etexilate/idarucizumabLack of efficacy following concomitant administration of idarucizumab and alteplase and second stroke due to hyper-coagulative effect of dabigatran-etexilate: case report
Reactions Weekly, 2019, 1765 (1) : 24 - 24
[39] Atorvastatin/dabigatran-etexilate interactionLeft atrial appendage thrombus and treatment failure: case report
Reactions Weekly, 2018, 1706 (1) : 68 - 68
[40] Apixaban/dabigatran-etexilate/rivaroxabanExcessive bleeding : 3 case reports
Reactions Weekly, 2022, 1920 (1) : 80 - 80

← 1 2 3 4 5 →